bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
RxNorm concept 1294619, clinical drug (scd). Prescribable name: bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule.
- RxCUI
- 1294619
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
Related concepts
- metronidazole 125 MG (SCDC, consists of)
- bismuth subcitrate 140 MG (SCDC, consists of)
- tetracycline hydrochloride 125 MG (SCDC, consists of)
- Oral Capsule (DF, has dose form)
- bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] (SBD, has tradename)
Linked data
NDCs
- 49884015124
- 49884015154
- 50742028313
- 61269038512
- 61269038612
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1294619 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1294619. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.